![](https://investorshub.advfn.com/uicon/825665.png?cb=1657717173)
Wednesday, August 17, 2022 12:26:08 PM
?? Bioscience is an early-stage bioscience company focused on the research, development, and commercialization of Traditional Chinese Medicine.
??Regencell Chairman and CEO, Yat-Gai Au recently purchased more than $5.9 million in RGC shares.
??Majority shareholders of Regencell are insider investors.
??Regencell is comfortably poised amidst turbulent market conditions, especially for a biotech stock.
??The company has a list of successful clinical trials, with more to come in the year.
https://seekingalpha.com/article/4534812-slow-and-steady-wins-the-race-with-regencell-bioscience
Recent RGC News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/20/2024 01:13:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/02/2024 11:04:03 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/15/2023 11:09:52 AM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/27/2023 08:15:39 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM